JP Patent

JP7495340B2 — カルノシン酸含有固体組成物及びカルノシン酸の溶出促進方法

Assigned to Fancl Corp · Expires 2024-06-04 · 2y expired

What this patent protects

Patent listed against Beleodaq.

Drugs covered by this patent

Patent Metadata

Patent number
JP7495340B2
Jurisdiction
JP
Classification
—
Expires
2024-06-04
Drug substance claim
No
Drug product claim
No
Assignee
Fancl Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.